Advertisement

Topics

Novartis Set 'Responsible' Price For Kymriah, Express Scripts Says

11:29 EDT 13 Sep 2017 | SCRIP

Drug pricing critic Steve Miller, chief medical officer with Express Scripts, praises Novartis gene therapy pricing in the context of...

      

Related Stories

 

Original Article: Novartis Set 'Responsible' Price For Kymriah, Express Scripts Says

NEXT ARTICLE

More From BioPortfolio on "Novartis Set 'Responsible' Price For Kymriah, Express Scripts Says"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...